PPIDT00007
Drug Information
| Name | Leuprolide |
|---|---|
| Sequence | PHWSYLLR |
| DrugBank_ID | DB00007 |
| Type | biotech |
| Indication | Leuprolide is indicated for the treatment of advanced prostate cancer [L13781, L34415] and as palliative treatment of advanced prostate cancer.[L13790] It is also used for the treatment of pediatric patients with central precocious puberty (CPP).[L13784, L13787] In combination with oral [norethisterone] (also known as norethindrone), leuprolide is also indicated for the initial treatment of the symptoms of endometriosis.[L10310] Finally, in combination with iron supplementation, leuprolide is indicated for the preoperative hematological improvement of anemic patients with uterine leiomyomata (uterine fibroids).[L13814] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| — | Subcutaneous |
42 mg
|
| — | Subcutaneous |
42 mg / syr
|
| Injection, emulsion | Subcutaneous |
42 mg/1mL
|
| Injection, emulsion | Subcutaneous |
42 mg/0.37g
|
| Injection, suspension | Subcutaneous |
42 mg
|
| Injection, powder, for solution | Parenteral |
3.75 mg/1.5ml
|
| Injection, powder, for solution | Parenteral |
22.5 MG
|
| Injection, powder, for solution | Parenteral |
45 MG
|
| Injection, powder, for solution | Parenteral |
7.5 MG
|
| Injection, powder, for suspension, extended release | Subcutaneous |
22.5 mg / syr
|
| Injection, powder, for suspension, extended release | Subcutaneous |
30 mg / syr
|
| Injection, powder, for suspension, extended release | Subcutaneous |
45 mg / syr
|
| Injection, powder, for suspension, extended release | Subcutaneous |
7.5 mg / syr
|
| Injection, suspension, extended release | Subcutaneous |
22.5 mg/0.375mL
|
| Injection, suspension, extended release | Subcutaneous |
30 mg/0.5mL
|
| Injection, suspension, extended release | Subcutaneous |
45 mg/0.375mL
|
| Injection, suspension, extended release | Subcutaneous |
7.5 mg/0.25mL
|
| Kit | Subcutaneous |
22.5 mg/0.375mL
|
| Kit | Subcutaneous |
30 mg/0.5mL
|
| Kit | Subcutaneous |
45 mg/0.375mL
|
| Kit | Subcutaneous |
7.5 mg/0.25mL
|
| Suspension | Subcutaneous |
7.500 mg
|
| Injection, powder, lyophilized, for suspension, extended release | Subcutaneous |
22.5 mg
|
| Injection, powder, lyophilized, for suspension, extended release | Subcutaneous |
45 mg
|
| Injection, powder, lyophilized, for suspension, extended release | Subcutaneous |
7.5 mg
|
| Injection, powder, for suspension | Subcutaneous |
4500000 mg
|
| Powder | Intramuscular |
22.5 mg/1vial
|
| Injection | Intramuscular |
22.5 mg
|
| Injection, powder, for solution | Subcutaneous |
22.5 MG
|
| Powder | Intramuscular |
45 mg/1vial
|
| Injection, solution | Intramuscular |
45 mg
|
| Injection, solution | Subcutaneous |
45 mg
|
| Injection, powder, for solution | Subcutaneous |
45 MG
|
| Injection, solution | Intramuscular |
|
| Injection, solution | Subcutaneous |
7.5 mg
|
| Powder | Intramuscular |
7.5 mg/1vial
|
| Injection, powder, for solution | Subcutaneous |
7.5 mg
|
| Injection, powder, for solution | Parenteral |
|
| Injection, powder, for suspension | Subcutaneous |
22.5 mg
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
2250000 mg
|
| Injection, powder, for suspension | Subcutaneous |
7.5 mg
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
750000 mg
|
| Injection, powder, for suspension | Parenteral |
750000 mg
|
| Injection | Intramuscular |
3.75 MG
|
| Injection, powder, for suspension | Intramuscular; Subcutaneous |
11.25 MG/ML
|
| Injection, powder, for suspension | Intramuscular; Subcutaneous |
3.75 MG/ML
|
| Injection, powder, for suspension, extended release | Intramuscular |
11.25 MG/2ML
|
| Injection, powder, for suspension, extended release | Intramuscular |
3.75 MG/2ML
|
| Injection, solution | Subcutaneous |
1 MG/0.2ML
|
| Powder | Intramuscular |
11.25 mg/1vial
|
| Injection, powder, for suspension | Subcutaneous |
3.75 mg
|
| Injection, suspension, extended release; kit | Subcutaneous |
45 mg/0.375mL
|
| Injection, powder, for suspension | Intramuscular |
1125000 mg
|
| Injection, powder, for suspension | Intramuscular |
3.75 mg
|
| Injection, powder, for suspension | Intramuscular |
375000 mg
|
| Injection, powder, for suspension | Intramuscular |
2250000 mg
|
| Powder | Intramuscular |
750000 mg
|
| Implant | Parenteral |
3.6 MG
|
| Implant | Parenteral |
5 MG
|
| Implant | Subcutaneous |
3.6 MG
|
| Implant | Subcutaneous |
5 MG
|
| Injection, solution | Subcutaneous |
1 mg/.2mL
|
| Injection, solution; kit | Subcutaneous; Topical |
|
| Kit | Subcutaneous |
|
| Kit | Subcutaneous; Topical |
1 mg/0.2mL
|
| Injection, powder, lyophilized, for suspension, extended release; kit | Intramuscular |
22.5 mg/2mL
|
| Liquid | Subcutaneous |
5 mg / mL
|
| Implant | Parenteral |
|
| Implant | Subcutaneous |
|
| Suspension | Parenteral |
3.75 mg
|
| Solution | Parenteral |
5 mg
|
| Suspension | Intramuscular |
11.25 MG
|
| Injection, solution | Subcutaneous |
5 mg/ml
|
| Suspension | Intramuscular |
11.250 mg
|
| Injection, powder, lyophilized, for solution | Intramuscular; Subcutaneous |
3.75 mg
|
| Injection, powder, lyophilized, for solution | Intramuscular; Subcutaneous |
11.25 mg
|
| Injection, powder, for solution | Intramuscular; Subcutaneous |
11.25 mg
|
| Injection, powder, for solution | Intramuscular; Subcutaneous |
3.75 mg
|
| Injection | Subcutaneous |
30 mg
|
| Injection, powder, for solution | Subcutaneous |
30 mg
|
| Injection, powder, lyophilized, for solution | Intramuscular; Subcutaneous |
|
| Injection | Subcutaneous |
5 mg/ml
|
| Injection, powder, lyophilized, for suspension; kit; tablet | Intramuscular; Oral; Topical |
|
| Suspension | — |
3.75 mg
|
| Kit | Subcutaneous; Topical |
5 mg/1mL
|
| Solution | Subcutaneous |
5 mg / mL
|
| Solution | Subcutaneous |
500000 mg
|
| Injection, powder, for suspension, extended release | Intramuscular |
11.25 mg / vial
|
| Injection, powder, for suspension, extended release | Intramuscular |
11.25 mg / syr
|
| Injection, powder, for suspension, extended release | Intramuscular |
15 mg / vial
|
| Injection, powder, for suspension, extended release | Intramuscular |
22.5 mg / syr
|
| Injection, powder, for suspension, extended release | Intramuscular |
3.75 mg / syr
|
| Injection, powder, for suspension, extended release | Intramuscular |
30 mg / syr
|
| Injection, powder, for suspension, extended release | Intramuscular |
7.5 mg / syr
|
| Injection, powder, lyophilized, for suspension | Intramuscular |
3.75 mg/1mL
|
| Injection, powder, lyophilized, for suspension | Intramuscular |
30 mg/1.5mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
22.5 mg/1.5mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
30 mg/1.5mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
45 mg/1.5mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
7.5 mg/1mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular; Topical |
|
| Kit | Intramuscular; Topical |
3.75 mg/1mL
|
| Injection, powder, for suspension | Intramuscular; Subcutaneous |
1125000 mg
|
| Injection, powder, lyophilized, for suspension | Intramuscular |
11.25 mg/1mL
|
| Injection, powder, lyophilized, for suspension | Intramuscular |
15 mg/1mL
|
| Injection, powder, lyophilized, for suspension | Intramuscular |
7.5 mg/1mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
11.25 mg/1.5mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
11.25 mg/1mL
|
| Injection, powder, lyophilized, for suspension; kit | Intramuscular |
15 mg/1mL
|
| Kit | Intramuscular; Topical |
11.25 mg/1mL
|
| Injection, powder, for suspension | Intramuscular; Subcutaneous |
3000000 mg
|
| Injection, powder, for suspension | Parenteral |
22.5 mg
|
| Injection, powder, for suspension | Parenteral |
|
| Injection, powder, for suspension, extended release | Intramuscular |
22.5 MG
|
| Suspension | Parenteral |
11.25 mg
|
| Solution | Parenteral |
500000 mg
|
| Suspension | Parenteral |
7.500 mg
|
| Injection, powder, for suspension | Subcutaneous |
30 mg
|
| Injection, powder, for solution | — |
1.88 mg
|
| Injection, powder, for solution | Parenteral |
3.75 mg
|
| Injection, powder, for solution; injection, solution | — |
3.75 mg
|
| Injection, powder, for solution | Parenteral |
11.25 mg
|
| Injection, powder, for solution | Parenteral |
1.88 mg
|
| Injection, powder, for suspension | Subcutaneous |
11.25 mg
|
| Kit | Subcutaneous; Topical |
|
| Injection, powder, for suspension, extended release; kit | Intramuscular |
22.5 mg / vial
|
| Injection, powder, for suspension, extended release; kit | Intramuscular |
3.75 mg / vial
|
| Powder | Intramuscular |
1.88 mg/1vial
|
| Powder | Intramuscular |
3.75 mg/1vial
|